Skip to main content

Morphic Holding, Inc.

MORFDelisted Aug 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001679363

Morphic Holding, Inc. was delisted on Aug 16, 2024; its insiders filed their last Form 4 on Aug 21, 2024; 136 institutions reported holding it in 13F filings for Q2 2024, worth $1.54B in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
136
Q2 2024, 0 vs. previous quarter
13F value
$1.54B
Reported value at the end of Q2 2024
Superinvestors holding
0
At the end of Q2 2024

From SEC filings, in USD.

Revenue, FY2023
$521.0K
−99.3% year over year
Net income, FY2023
-$152.1M
No comparable prior period
Free cash flow, FY2023
-$113.6M
No comparable prior period
Revenue, Q2 FY2024
$0
No comparable prior period

Revenue flow, FY2023

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2023: $152.1M (29192.9% of revenue).

Superinvestors holding MORF, Q2 2024

Go to the superinvestors tab

No superinvestor reported holding MORF at the end of Q2 2024.

Latest insider trades

See all insider trades

Open-market purchases and sales by Morphic Holding, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 10, 2024 (view filing)Jul 82 daysRogers BrucePRESIDENTSSale−20.0K$55.79−$1.12M−11.8%149.9K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysSchegerin MarcCFO and COOSSale−43.9K$55.80−$2.45M−53.7%37.9K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysTipirneni Praveen P.President and CEOSSale−21.6K$55.79−$1.20M−33.7%42.5K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysFarrell Robert E JrSVP Finance and CAOSSale−30.3K$55.80−$1.69M−68.7%13.8K after10b5-1
Jul 10, 2024 (view filing)Jul 82 daysDeVaul WilliamGeneral Counsel and SecretarySSale−10.0K$55.79−$557.9K−30.3%23.0K after10b5-1
Jan 17, 2024 (view filing)Jan 161 dayTipirneni Praveen P.CEOSSale−13.9K$27.49−$382.7K−24.9%42.0K after
Jan 17, 2024 (view filing)Jan 161 daySchegerin MarcCFO and COOSSale−6.04K$27.49−$166.1K−13.9%37.5K after
Jan 17, 2024 (view filing)Jan 161 dayRogers BrucePresidentSSale−6.31K$27.49−$173.6K−4.3%142.0K after
Jan 17, 2024 (view filing)Jan 161 dayFarrell Robert E JrSVP Finance and CAOSSale−5.09K$27.49−$139.9K−12.7%35.0K after
Jan 17, 2024 (view filing)Jan 161 dayDeVaul WilliamGeneral Counsel and SecretarySSale−4.51K$27.49−$124.0K−16.4%23.0K after

Top 10 13F holders, Q2 2024

See all 136 holders

The largest institutional positions in Morphic Holding, Inc. at the end of Q2 2024; share changes are against Q1 2024.

Institutions holding MORF in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC7,514,010$256.0M0.02%+8,426+0.1%Added
Wellington Management Group LLP5,814,446$198.1M0.04%+1,791,462+44.5%Added
EcoR1 Capital, LLC4,982,945$169.8M5.20%+2,598,561+109.0%Added
BlackRock Inc.3,527,564$120.2M0.00%+244,240+7.4%Added
Artal Group S.A.2,525,998$86.1M2.21%+312,810+14.1%Added
Vanguard Group Inc2,215,949$75.5M0.00%−45,246−2.0%Reduced
Price T Rowe Associates Inc2,207,187$75.2M0.01%−316,399−12.5%Reduced
Woodline Partners LP1,783,202$60.8M0.58%+1,683,202+1,683.2%Added
State Street Corp1,638,108$55.8M0.00%−1,027,402−38.5%Reduced
Point72 Asset Management, L.P.1,461,302$49.8M0.16%−3,225,798−68.8%Reduced